Salem Erode Investments Limited has scheduled a board meeting for August 29, 2026, to approve the final terms of its proposed rights issue. The company seeks to finalize critical parameters including the issue price, record date, and rights entitlement ratio.

This corporate action follows a previous board meeting held on March 24, 2026, which approved the equity share issuance to eligible shareholders. The proposal aligns with the Companies Act, 2013, and the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. BSE Limited granted in-principle approval for the rights issue on August 14, 2026.

Meeting Agenda

The upcoming board session will address several key components required for the successful execution of the capital raise:

• Determination of the issue price
• Fixation of the record date
• Establishment of the rights entitlement ratio
• Approval of the Letter of Offer and Application Form
• Authorization of the Rights Entitlement Letter
• Finalization of the rights issue schedule

The company notified the stock exchange of this meeting under Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Trading Window Closure

Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for designated persons has been closed. This restriction applies to promoters, directors, key managerial personnel, and their immediate relatives from August 25, 2026, until 48 hours after the dissemination of the board meeting outcome.

The intimation was uploaded on the company’s website on August 25, 2026.

Salem Erode Investments has allotted unlisted secured redeemable non-convertible debentures (NCDs) aggregating to ₹3,69,50,000 on a private placement basis. The Debenture and Bond Committee of the Board of Directors approved the allotment during a meeting held on August 01, 2026. This capital raise strengthens the financial link between the subsidiary and its holding company, ICL Fincorp Limited, which subscribed to the majority of the issue.

The committee approved the allotment of 36,950 debentures, each with a face value of ₹1,000. The total value of the issuance stands at ₹3,69,50,000. The transaction was executed in compliance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Allotment Details

ICL Fincorp Limited, the holding company of Salem Erode Investments, was allotted NCDs aggregating to ₹3,00,00,000. The remaining portion of the issuance, amounting to ₹69,50,000, was allotted to other subscribers under the private placement framework. The document does not specify the coupon rate or maturity tenor for these instruments.

Committee Proceedings

The Debenture and Bond Committee convened on August 01, 2026, to finalize the allotment process. The meeting commenced at 02:00 P.M. IST and concluded at 02:30 P.M. IST. Visakh T V, Company Secretary of Salem Erode Investments, certified the outcome of the meeting. The company has submitted the disclosure to BSE Limited pursuant to regulatory requirements.

What the Numbers Show

The concentration of the allotment within the group structure is notable. With ₹3,00,00,000 of the ₹3,69,50,000 total issuance going to ICL Fincorp Limited, approximately 81% of the debt instrument was absorbed by the holding company. This suggests the primary objective of the private placement is internal capital structuring rather than raising funds from external third-party investors. The secured nature of the debentures indicates that specific assets or collateral back this liability, providing a layer of security for the holding company’s investment.